The prostate cancer-associated lncRNA PCGEM1 was recently shown to promote glucose uptake in prostate cancer cell lines, conferring these cells an overall metabolic advantage by regulating at the transcriptional level, not only glucose metabolism, but also glutamine metabolism, the pentose phosphate catabolic pathway, the tricarboxylic acid cycle and fatty acids and nucleotides synthesis pathways [35]. Here, PCGEM1 is linked to prostate cancer.